Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
2000 1
2001 2
2002 2
2004 2
2006 1
2007 2
2008 19
2009 15
2010 21
2011 24
2012 16
2013 17
2014 17
2015 17
2016 18
2017 14
2018 11
2019 7
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

183 results
Results by year
Filters applied: . Clear all
Page 1
Oncolytic virotherapy.
Russell SJ, Peng KW, Bell JC. Russell SJ, et al. Nat Biotechnol. 2012 Jul 10;30(7):658-70. doi: 10.1038/nbt.2287. Nat Biotechnol. 2012. PMID: 22781695 Free PMC article. Review.
Epigenetics in breast and prostate cancer.
Wu Y, Sarkissyan M, Vadgama JV. Wu Y, et al. Methods Mol Biol. 2015;1238:425-66. doi: 10.1007/978-1-4939-1804-1_23. Methods Mol Biol. 2015. PMID: 25421674 Free PMC article. Review.
Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.
Dhanasekaran R, Nault JC, Roberts LR, Zucman-Rossi J. Dhanasekaran R, et al. Gastroenterology. 2019 Jan;156(2):492-509. doi: 10.1053/j.gastro.2018.11.001. Epub 2018 Nov 4. Gastroenterology. 2019. PMID: 30404026 Free PMC article. Review.
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.
Yu J, Qin B, Moyer AM, Nowsheen S, Liu T, Qin S, Zhuang Y, Liu D, Lu SW, Kalari KR, Visscher DW, Copland JA, McLaughlin SA, Moreno-Aspitia A, Northfelt DW, Gray RJ, Lou Z, Suman VJ, Weinshilboum R, Boughey JC, Goetz MP, Wang L. Yu J, et al. J Clin Invest. 2018 Jun 1;128(6):2376-2388. doi: 10.1172/JCI97924. Epub 2018 Apr 30. J Clin Invest. 2018. PMID: 29708513 Free PMC article.
Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway.
Kurmi K, Hitosugi S, Yu J, Boakye-Agyeman F, Wiese EK, Larson TR, Dai Q, Machida YJ, Lou Z, Wang L, Boughey JC, Kaufmann SH, Goetz MP, Karnitz LM, Hitosugi T. Kurmi K, et al. Cell Metab. 2018 Dec 4;28(6):833-847.e8. doi: 10.1016/j.cmet.2018.08.008. Epub 2018 Aug 30. Cell Metab. 2018. PMID: 30174304 Free PMC article.
GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score.
Yang JD, Addissie BD, Mara KC, Harmsen WS, Dai J, Zhang N, Wongjarupong N, Ali HM, Ali HA, Hassan FA, Lavu S, Cvinar JL, Giama NH, Moser CD, Miyabe K, Allotey LK, Algeciras-Schimnich A, Theobald JP, Ward MM, Nguyen MH, Befeler AS, Reddy KR, Schwartz M, Harnois DM, Yamada H, Srivastava S, Rinaudo JA, Gores GJ, Feng Z, Marrero JA, Roberts LR. Yang JD, et al. Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):531-538. doi: 10.1158/1055-9965.EPI-18-0281. Epub 2018 Nov 21. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 30464023 Free PMC article.
Gene-Specific Variant Classifier (DPYD-Varifier) to Identify Deleterious Alleles of Dihydropyrimidine Dehydrogenase.
Shrestha S, Zhang C, Jerde CR, Nie Q, Li H, Offer SM, Diasio RB. Shrestha S, et al. Clin Pharmacol Ther. 2018 Oct;104(4):709-718. doi: 10.1002/cpt.1020. Epub 2018 Feb 2. Clin Pharmacol Ther. 2018. PMID: 29327356 Free PMC article.
Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells.
Paulus A, Manna A, Akhtar S, Paulus SM, Sharma M, Coignet MV, Jiang L, Roy V, Witzig TE, Ansell SM, Allan J, Furman R, Aulakh S, Manochakian R, Ailawadhi S, Chanan-Khan AA, Sher T. Paulus A, et al. Br J Haematol. 2018 Oct;183(2):196-211. doi: 10.1111/bjh.15515. Epub 2018 Aug 6. Br J Haematol. 2018. PMID: 30080238 Free PMC article.
Targeting CD38 Enhances the Antileukemic Activity of Ibrutinib in Chronic Lymphocytic Leukemia.
Manna A, Aulakh S, Jani P, Ahmed S, Akhtar S, Coignet M, Heckman M, Meghji Z, Bhatia K, Sharma A, Sher T, Alegria V, Malavasi F, Chini EN, Chanan-Khan A, Ailawadhi S, Paulus A. Manna A, et al. Clin Cancer Res. 2019 Jul 1;25(13):3974-3985. doi: 10.1158/1078-0432.CCR-18-3412. Epub 2019 Apr 2. Clin Cancer Res. 2019. PMID: 30940652 Free PMC article.
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.
Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR. Kopetz S, et al. J Clin Oncol. 2009 Aug 1;27(22):3677-83. doi: 10.1200/JCO.2008.20.5278. Epub 2009 May 26. J Clin Oncol. 2009. PMID: 19470929 Free PMC article. Clinical Trial.
183 results
Jump to page
Feedback